Literature DB >> 142350

A histochemical study of bone marrow hypoplasia in anorexia nervosa.

P J Cornbleet, R C Moir, P L Wolf.   

Abstract

The bone marrow in patients with anorexia nervosa is commonly hypoplastic with transformation of marrow fat. The normal fat cells which appear clear and open in the marrow are surrounded by an amorphous, gelatinous material, thought to represent an increase in the ordinary acid mucopolysaccharide ground substance of the bone marrow. Since this lesion has a similar appearance grossly and microscopically to the lesion of serous fat atrophy found in cachectic patients, we have compared the histochemical properties of this amorphous material in a bone marrow from a patient with anorexia nervosa and from cachectic patients with epicardial serous fat atrophy and with the background substance in hypoplastic marrows. Both this fat-associated deposition in the bone marrow and serous fat atrophy were found to be predominantly a hyaluronic acid mucopolysaccharide. In contrast, the background substance contained a less acid mucopolysaccharide. The increase in bone marrow acid mucopolysaccharide in anorexia nervosa may represent a serous fat atrophy change rather than an increase in ground substance.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 142350     DOI: 10.1007/bf00427118

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histol        ISSN: 0340-1227


  3 in total

1.  Marrow hypoplasia in anorexia nervosa.

Authors:  H A Pearson
Journal:  J Pediatr       Date:  1967-08       Impact factor: 4.406

2.  The haematology of anorexia nervosa.

Authors:  M J Mant; B S Faragher
Journal:  Br J Haematol       Date:  1972-12       Impact factor: 6.998

3.  Quantitation of bone marrow reticulin--a normal range.

Authors:  D E Bauermeister
Journal:  Am J Clin Pathol       Date:  1971-07       Impact factor: 2.493

  3 in total
  8 in total

1.  Observations on the haemopoietic response to critical illness.

Authors:  R J Amos; M Deane; C Ferguson; G Jeffries; C J Hinds; J A Amess
Journal:  J Clin Pathol       Date:  1990-10       Impact factor: 3.411

Review 2.  Bone-Fat Interaction.

Authors:  Elizabeth Rendina-Ruedy; Clifford J Rosen
Journal:  Endocrinol Metab Clin North Am       Date:  2016-11-24       Impact factor: 4.741

3.  Caloric restriction leads to high marrow adiposity and low bone mass in growing mice.

Authors:  Maureen J Devlin; Alison M Cloutier; Nishina A Thomas; David A Panus; Sutada Lotinun; Ilka Pinz; Roland Baron; Clifford J Rosen; Mary L Bouxsein
Journal:  J Bone Miner Res       Date:  2010-09       Impact factor: 6.741

Review 4.  Preclinical models for investigating how bone marrow adipocytes influence bone and hematopoietic cellularity.

Authors:  Ziru Li; Ormond A MacDougald
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2021-05-01       Impact factor: 5.667

Review 5.  Standardised Nomenclature, Abbreviations, and Units for the Study of Bone Marrow Adiposity: Report of the Nomenclature Working Group of the International Bone Marrow Adiposity Society.

Authors:  Nathalie Bravenboer; Miriam A Bredella; Christophe Chauveau; Alessandro Corsi; Eleni Douni; William F Ferris; Mara Riminucci; Pamela G Robey; Shanti Rojas-Sutterlin; Clifford Rosen; Tim J Schulz; William P Cawthorn
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-24       Impact factor: 5.555

6.  Gelatinous transformation of bone marrow in a rabbit.

Authors:  Flavio H Alonso; Danielle K Tarbert; BinXi Wu; Paula Rodriguez; Mary M Christopher
Journal:  J Vet Diagn Invest       Date:  2021-07-11       Impact factor: 1.569

7.  Gelatinous marrow transformation: a series of 11 cases from a tertiary care centre in South India.

Authors:  Sreeya Das; Pritinanda Mishra; Rakhee Kar; Debdatta Basu
Journal:  Turk J Haematol       Date:  2014-06-10       Impact factor: 1.831

8.  Increased Bone Marrow Adiposity in a Context of Energy Deficit: The Tip of the Iceberg?

Authors:  Olfa Ghali; Nathalie Al Rassy; Pierre Hardouin; Christophe Chauveau
Journal:  Front Endocrinol (Lausanne)       Date:  2016-09-16       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.